bf/NASDAQ:CTSO_icon.jpeg

COM:CYTOSORBENTS

CytoSorbents Corporation

  • Stock

USD

Last Close

0.89

22/11 21:00

Market Cap

53.76M

Beta: -

Volume Today

76.86K

Avg: -

Description

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical car...Show More

competitor of